FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
Acral lentiginous melanoma with subsequent spontaneous vitiligo vulgaris: a case report and literature review
566PDF: 272SUPPLEMENTARY MATERIAL: 20HTML: 0 -
Optimizing targeted therapy for metastatic melanoma: a combination of encorafenib and trametinib beyond standard protocols
764PDF: 284SUPPLEMENTARY MATERIAL: 68HTML: 1 -
27 | Real-world data for malignant melanoma stage II adjuvant therapy Silvana Cozzolino1, Antonino Colloca1, Miriam Forte1, Francesco Caraglia1, Alfonso Esposito1, Maria Cristina Giugliano1, Eleonora Cioli1, Marcella Scala2, Maria Chiara Sergi3, Teresa Del Giudice4, Francesca Sparano5, Immacolata Paciolla6, Mariangela Pasqualoni7, Luigi Formisano2, Stefania Napolitano1, Antonio Maria Grimaldi1, Paolo Antonio Ascierto5, Fortunato Ciardiello1, Teresa Troiani1, Vincenzo De Falco1 | 1Medical Oncology, Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples; 2Department of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy; 3Division of Medical Oncology, "Mons. A.R. Dimiccoli" Hospital, Barletta; 4Nuclear Medicine Unit, "Mater Domini" University Hospital, Catanzaro; 5Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples; 6Medical Oncology Unit, AORN "San Pio", Benevento, Italy; 7Medical Oncology Unit, ASL Taranto, Italy.
317 -
New and emerging therapies in cutaneous T-cell lymphoma
1046PDF: 562HTML: 92 -
18 | Surgical management of pregnancy-associated melanoma: a single institution experience with thirty-three pregnant patients B. Taglione1, I. Mattavelli1, A. Maurichi1, G. Gallino1, D. Cortese1, E. Tolomio1, G. Spadola1, C. Barbieri1, S. Mercurio1, B. Scoppio1, B. Valeri2, M. Cossa2, M. Maccauro3, L. Di Guardo4, M. Del Vecchio4, M. Santinami1, R. Patuzzo1 | 1IRCCS Istituto Nazionale Tumori Milano, Surgery, Milano; 2IRCCS Istituto Nazionale Tumori Milano, Pathology, Milano; 3IRCCS Istituto Nazionale Tumori Milano, Nuclear Medicine, Milano; 4IRCCS Istituto Nazionale Tumori Milano, Medical Oncology, Milano, Italy.
316 -
35 | Real-world outcomes of targeted therapy in stage IV melanoma after relapse on adjuvant dabrafenib and trametinib: insights from a single-center cohort Rossella Villani, Chiara Bungaro, Anna Cecere, Ileana De Roma, Sabino Strippoli, Michele Guida | Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
324 -
-
28 | Efficacy and toxicity outcomes with doublet immunotherapy in metastatic melanoma: the real-world REALIPINIVO study Miriam Forte1, Francesco Caraglia1, Silvana Cozzolino1, Antonino Colloca1, Alfonso Esposito1, Maria Cristina Giugliano1, Eleonora Cioli1, Marcella Scala2, Francesca Sparano5, Maria Chiara Sergi3, Teresa Del Giudice4, Immacolata Paciolla6, Luigi Formisano2, Stefania Napolitano1, Antonio Maria Grimaldi6, Paolo Antonio Ascierto5, Fortunato Ciardiello1, Teresa Troiani1, Vincenzo De Falco1 | 1Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples; 2Department of Clinical Medicine and Surgery, Federico Il University, Naples; 3Unità Operativa Complessa di Oncologia Medica, Ospedale "Mons. A.R. Dimiccoli", Barletta; 4Nuclear Medicine Unit, "Mater Domini" University Hospital, Catanzaro; 5Istituto Nazionale Tumori IRCCS Fondazione Giovanni Pascale Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Napoli; 6Medical Oncology Unit AORN "San Pio", Benevento, Italy.
304
1 - 22 of 22 items

